Palisade Bio (PALI) Non Operating Income (2010 - 2026)
Palisade Bio's (PALI) quarterly Non Operating Income came in at $1.1 million in Q1 2026, up 1335.0% year-on-year from $80000.0 in Q1 2025, and up 6.1% on a QoQ basis from $1.1 million in Q4 2025.
Palisade Bio (PALI) Non Operating Income (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Non Operating Income data on file, last reported at $1.1 million in Q1 2026.
- On a quarterly basis, Non Operating Income rose 1335.0% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a 560.0% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 202.85% from the prior year.
- Non Operating Income for Q1 2026 stood at $1.1 million, up from $1.1 million in the prior quarter.
- Over the last five years, Non Operating Income for PALI reached as high as $1.2 million in Q2 2022 and fell as low as -$317000.0 in Q1 2022.
- Historically, Non Operating Income has averaged $298529.4 across 5 years, with a median of $146000.0 in 2024.
- Across the five-year window, Non Operating Income tumbled 97.49% in 2022 and jumped 2747.37% in 2025, its largest moves.
- Year by year, Non Operating Income stood at $128000.0 in 2022, then soared by 42.97% to $183000.0 in 2023, then sank by 79.23% to $38000.0 in 2024, then soared by 2747.37% to $1.1 million in 2025, then increased by 6.1% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $54000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | 1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 54,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Jun 30, 2024 | 131,000.00 |
| Mar 31, 2024 | 146,000.00 |
| Dec 31, 2023 | 183,000.00 |
| Sep 30, 2023 | 182,000.00 |
| Jun 30, 2023 | 216,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Dec 31, 2022 | 128,000.00 |
| Sep 30, 2022 | 422,000.00 |
| Jun 30, 2022 | 1.23 Mn |
| Mar 31, 2022 | -317,000.00 |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 11.10 Mn |
| Jun 30, 2021 | 1.11 Mn |